Mayne Pharma gets FDA approval to sell epirubicin

By Elaine Rigoli

Tampa, Fla., Sept. 19 - Mayne Pharma Ltd. received marketing authorization from the Food and Drug Administration for the company's freeze-dried epirubicin product.

The Melbourne, Australia, specialty pharmaceutical company said epirubicin, sold under the brand name Ellence, generated sales of about $68 million in the U.S. market.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.